Sabiia Seb
PortuguêsEspañolEnglish
Embrapa
        Busca avançada

Botão Atualizar


Botão Atualizar

Registro completo
Provedor de dados:  BJMBR
País:  Brazil
Título:  Gene expression profiling of clinical stages II and III breast cancer
Autores:  Folgueira,M.A.A.K.
Brentani,H.
Katayama,M.L.H.
Patrão,D.F.C.
Carraro,D.M.
Mourão Netto,M.
Barbosa,E.M.
Caldeira,J.R.F.
Abreu,A.P.S.
Lyra,E.C.
Kaiano,J.H.L.
Mota,L.D.
Campos,A.H.J.F.M.
Maciel,M.S.
Dellamano,M.
Caballero,O.L.S.D.
Brentani,M.M.
Data:  2006-08-01
Ano:  2006
Palavras-chave:  Breast cancer
CDNA microarray
Clinical stage
Gene expression
Resumo:  Clinical stage (CS) is an established indicator of breast cancer outcome. In the present study, a cDNA microarray platform containing 692 genes was used to identify molecular differences between CSII and CSIII disease. Tumor samples were collected from patients with CSII or CSIII breast cancer, and normal breast tissue was collected from women without invasive cancer. Seventy-eight genes were deregulated in CSIII tumors and 22 in CSII tumors when compared to normal tissue, and 20 of them were differentially expressed in both CSII and CSIII tumors. In addition, 58 genes were specifically altered in CSIII and expression of 6 of them was tested by real time RT-PCR in another cohort of patients with CSII or CSIII breast cancer and in women without cancer. Among these genes, MAX, KRT15 and S100A14, but not APOBEC3G or KRT19, were differentially expressed on both CSIII and CSII tumors as compared to normal tissue. Increased HMOX1 levels were detected only in CSIII tumors and may represent a molecular marker of this stage. A clear difference in gene expression pattern occurs at the normal-to-cancer transition; however, most of the differentially expressed genes are deregulated in tumors of both CS (II and III) compared to normal breast tissue.
Tipo:  Info:eu-repo/semantics/article
Idioma:  Inglês
Identificador:  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000800013
Editor:  Associação Brasileira de Divulgação Científica
Relação:  10.1590/S0100-879X2006000800013
Formato:  text/html
Fonte:  Brazilian Journal of Medical and Biological Research v.39 n.8 2006
Direitos:  info:eu-repo/semantics/openAccess
Fechar
 

Empresa Brasileira de Pesquisa Agropecuária - Embrapa
Todos os direitos reservados, conforme Lei n° 9.610
Política de Privacidade
Área restrita

Embrapa
Parque Estação Biológica - PqEB s/n°
Brasília, DF - Brasil - CEP 70770-901
Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco

Valid HTML 4.01 Transitional